BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Society for Women's Health Research - ECPv6.16.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://swhr.org
X-WR-CALDESC:Events for Society for Women's Health Research
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230207T120000
DTEND;TZID=America/New_York:20230207T130000
DTSTAMP:20240724T140141Z
CREATED:20230103T225254Z
LAST-MODIFIED:20240724T140141Z
UID:10000425-1675771200-1675774800@swhr.org
SUMMARY:Coverage and Access Issues Affecting Women Living with Autoimmune Diseases
DESCRIPTION:The rate of autoimmune diseases and conditions in the United States is rising—and women are disproportionately affected. \nGenerally\, autoimmune diseases cannot be cured\, so treatment focuses on managing symptoms and slowing the progression and impacts of the disease. However\, utilization management (UM) tools\, such as prior authorization and step therapy\, are increasingly being used by payers and can cause delays in care\, which can be devastating for patients\, resulting in disease progression and higher costs over time. \nIn this webinar\, panelists reviewed coverage and access issues that could negatively affect those with autoimmune diseases and conditions\, the tenants of prior authorization and step therapy\, discuss the role these policies can play in patient outcomes and on providers\, and how current policies could be modified to better serve individuals living with autoimmune diseases and conditions. \nWhile this webinar is open to the public\, SWHR encourages new members of the 118th Congress and their staff to attend. *This event is widely attended and relevant to official duties.  \nThis event is free and open to the public. \n  \nCheck out the full SWHR 2023 Autoimmune Policy series: \n\nThe Growing National Burden of Autoimmune Diseases and the Role of Policy in Improving Outcomes (January 17\, 2023)\nCoverage and Access Issues Affecting Women Living with Autoimmune Diseases (February 7\, 2023)\nThe Role of Federal Agencies in Supporting Women with Autoimmune Diseases and Conditions (March 17\, 2023)\nDiversity in Autoimmune Clinical Trials: Addressing Areas of Need and Opportunity (March 30\, 2023)
URL:https://swhr.org/event/coverage-and-access-issues-affecting-women-living-with-autoimmune-diseases/
LOCATION:Virtual Event
CATEGORIES:Policymaker Event,Public Event,Science Event,SWHR Event,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230213T130000
DTEND;TZID=America/New_York:20230213T134500
DTSTAMP:20241206T203322Z
CREATED:20230106T224742Z
LAST-MODIFIED:20241206T203322Z
UID:10000426-1676293200-1676295900@swhr.org
SUMMARY:Taking it to Heart: Addressing Cardiovascular Disease in Women
DESCRIPTION:Diagnostic tests and procedures offer opportunities to detect diseases\, monitor disease progression\, guide treatments\, and evaluate treatment effectiveness. Some diagnostic tests are invasive\, such as a biopsy or endoscopy; whereas others are noninvasive\, such as x-rays and ultrasound imaging procedures. \nInnovations in diagnostics provide access to health information\, helping women make informed decisions about their health care at every stage of their lives. Screening and diagnostic testing can lead to earlier detection of disease\, improve health outcomes\, and contribute toward reducing health disparities among women. Research seeking to expand the development and availability of diagnostic tools for conditions that exclusively\, differently\, or disproportionately affect women is invaluable in furthering women’s health across sectors. \nSWHR is hosting a series of public forums to share educational information about the importance and value of innovative diagnostics throughout the lifespan and across disease states and conditions. The events discuss how to improve health outcomes for diseases and conditions that disproportionately or differently affect women\, with special a focus on cancer and healthy aging. \nThe 2023 SWHR Value of Diagnostics within Women’s Health series includes: \n\nTaking it to Heart: Addressing Cardiovascular Disease in Women (February\, 13\, 2023)\nPutting our Heads Together: Diagnostic Innovations for Alzheimer’s Disease (June 6\, 2023)\nClearing the Air About Lung Cancer in Women (November 17\, 2023)\n\n  \nFollow the conversation on Twitter at @SWHR and #SWHRtalksDiagnostics. \nThis event is free and open to the public.
URL:https://swhr.org/event/taking-it-to-heart-addressing-cardiovascular-disease-in-women/
LOCATION:Virtual Event
CATEGORIES:Patient Event,Public Event,Science Event,SWHR Event,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230214T130000
DTEND;TZID=America/New_York:20230214T140000
DTSTAMP:20241114T184146Z
CREATED:20230118T214157Z
LAST-MODIFIED:20241114T184146Z
UID:10000430-1676379600-1676383200@swhr.org
SUMMARY:PRGLAC Then and Now: Where We Are and Where We're Going
DESCRIPTION:The 21st Century Cures Act established the Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) to advise the Secretary of the U.S. Department of Health and Human Services regarding gaps in knowledge and research on safe and effective therapies for pregnant women and lactating women. The Task Force’s work culminated in a set of recommendations based on information gleaned during four open meetings and a public comment period. The central theme of those recommendations was “the need to alter cultural assumptions that have significantly limited scientific knowledge of therapeutic product safety\, effectiveness\, and dosing for pregnant and lactating women.” \nDuring this congressional briefing and national webinar\, designed specifically for—but not limited to—members of the 118th Congress\, panelists reviewed the state of PRGLAC\, the PRGLAC recommendations and their implementation status\, the current legislative and regulatory landscape\, and review actions that can be taken at the federal level to increase representation of these populations in clinical trials. \n*This event is widely attended and relevant to official duties. \nThis event is part of a series about the inclusion of pregnant and lactating peoples in research. The full series includes: \n\nAddressing Concerns and Considerations Surrounding the Inclusion of Pregnant and Lactating Populations in Research (December 6\, 2022)\nPregnant and Lactating Populations in Research: How Leaving These Populations Out Leaves Them Behind (January 26\, 2023)\nPRGLAC Then and Now: Where We Are and Where We’re Going (February 14\, 2023)
URL:https://swhr.org/event/prglac-then-and-now-where-we-are-and-where-were-going/
LOCATION:Virtual Event
CATEGORIES:Congressional Briefing,Policymaker Event,Public Event,Science Event,SWHR Event,Webinar
END:VEVENT
END:VCALENDAR